by Joel Rothman | Jan 8, 2010 | NutriSupLaw
Marketers of nutritional supplements often complain that they do not know what the FDA wants. Even after the agency sends a warning letter about misleading claims and advertising, its staff does not explain what would fall within the rules. That’s the reality;...
by Joel Rothman | Jan 3, 2010 | NutriSupLaw
2009 was an incredible year for the dietary supplement industry. While the rest of American business floundered amidst the depths of a recession, the dietary supplement business thrived. Americans concerned about maintaining their good health stocked up on...
by Joel Rothman | Dec 24, 2009 | NutriSupLaw
The rules are different here in the United States. Hyde Park Holistic Center in Cincinnati recently received a warning letter from the Food & Drug Administration that read like many others having to do with nutritional supplements and the H1N1 virus. In China,...
by Joel Rothman | Dec 13, 2009 | NutriSupLaw
The first paragraph in the New York Times story said it all: “The Drug Enforcement Administration has classified as controlled substances three steroids that are marketed as dietary supplements, but an antidoping official warned that new steroids have taken...
by Joel Rothman | Nov 16, 2009 | NutriSupLaw
Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyper-linked line that warns consumers about the potential dangers of a drug....